
PharmaShots Weekly Snapshot (November 24 - 29, 2018)
Published: 29 Nov, 2018 | Tags: Novartis, Gilenya, (fingolimod), Receives, EU, Approval, Relapsing-Remitting, Forms, Multiple Sclerosis (RRMS), 10 to <18 yrs, PARADIGMS study, P-III
Published: 29 Nov, 2018 | Tags: NTU Singapore, TTSH, Develops, AI based, Medical Device, Early, Detection, Congestive Heart Failure
Published: 29 Nov, 2018 | Tags: Vertex, Kalydeco, (ivacaftor), Receives, FDAs, Expanded, Label, Approval , Cystic Fibrosis (CF), Aged 12 to < 24 Months
Published: 29 Nov, 2018 | Tags: Astellas, Xospata, gilteritinib, Receives, FDA s, Approval, Treatment, Relapsed/Refactory Acute Myeloid Leukemia, (AML), Adults
Published: 28 Nov, 2018 | Tags: ElectroCore, GammaCore (nVNS), Receives, FDA, 510(k), Approval, Cluster Headache, Adults
Published: 28 Nov, 2018 | Tags: Q BioMed, Acquires,Rights, Metastron, GE Healthcare
Clearance, CLIA Waiver, Respiratory Infections
Published: 27 Nov, 2018 | Tags: Beigene, Signs, Exclusive, License, Development, Agreement, Zymeworks, ZW25, ZW49, Azymetric platform, Efect platforms
Published: 27 Nov, 2018 | Tags: Novo, Reports, Improved, Results, Oral Semaglutide, PIONEER 9 Study, T2D, Victoza
Published: 27 Nov, 2018 | Tags: Loxo, Vitrakvi, (larotrectinib), Receives, the US FDA, Approval, Treatment, Solid Tumors, Adults, Pediatric Patient
Published: 26 Nov, 2018 | Tags: Genentech, ACTpen, Receives, FDAs, Approval, Actemra (tocilizumab), Treat, RA, Giant Cell Arteritis, Two Forms of Juvenile Arthritis
Published: 27 Nov, 2018 | Tags: Sandozs, Ziextenzo, (pegfilgrastim), Receives, EU, Approval, Reduction, Duration, Neutropenia, Eighth, Approval, Febrile Neutropenia
Published: 26 Nov, 2018 | Tags: RegenxBio, Rocket, Signs, Exclusive, Worldwide, License, Agreement, NAV AAV9 Vector
Published: 26 Nov, 2018 | Tags: Bristol-Myers, Reports, Unmet, Results, P-III Checkmate-451 Study, Patients, 1L, Extensive-Stage SCLC
Published: 23 Nov, 2018 | Tags: Novartis, Receives, EU, Approval, One-Time Gene Therapy, Luxturna, Control group, Vision improvement, Retinal Disease
Published: 23 Nov, 2018 | Tags: Mundipharma, Receives, EU approval, Pelmeg, Biosimilar, Neutropenia, Febrile neutropenia Cytotoxic CT, Malignancy, Neulasta, G-CSF, CHMP
Published: 23 Nov, 2018 | Tags: Indivior, Receives, Health Canada, Approval, Sublocade, Moderate to Severe, Opioid Use Disorder(OUD), Clinical Trials, Injection
- Mercks Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate) & Pifeltro (doravirine) Receives EUs Approval for the Treatment of HIV-1 Infection
